RVL Pharmaceuticals's market cap is currently $111.00. The company's EPS TTM is $; its P/E ratio is ―; RVL Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 49.72M	$ 17.50M	$ 27.76M	$ 240.03M	$ 263.70M
Gross Profit	$ 40.27M	$ 13.88M	$ 24.47M	$ 128.40M	$ 121.75M
Operating Income	$ -58.99M	$ -82.75M	$ -90.65M	$ -280.69M	$ 5.68M
EBITDA	$ -48.23M	$ -70.34M	$ -69.67M	$ -222.80M	$ -16.28M
Net Income	$ -51.69M	$ -64.92M	$ -79.59M	$ -270.90M	$ -109.68M
Balance Sheet
Cash & Short-Term Investments	$ 44.54M	$ 43.51M	$ 114.05M	$ 95.86M	$ 70.83M
Total Assets	$ 128.51M	$ 144.67M	$ 370.95M	$ 463.25M	$ 827.14M
Total Debt	$ 57.49M	$ 47.65M	$ 221.62M	$ 273.30M	$ 268.83M
Net Debt	$ 12.95M	$ 7.20M	$ 107.56M	$ 177.43M	$ 198.00M
Total Liabilities	$ 77.42M	$ 67.94M	$ 277.09M	$ 348.55M	$ 443.30M
Stockholders' Equity	$ 51.09M	$ 76.73M	$ 93.86M	$ 114.71M	$ 383.85M
Cash Flow
Free Cash Flow	$ -38.56M	$ -56.51M	$ 14.46M	$ 29.53M	$ 33.41M
Operating Cash Flow	$ -37.81M	$ -54.73M	$ 17.59M	$ 33.57M	$ 37.56M
Investing Cash Flow	$ 126.00K	$ 116.45M	$ -3.08M	$ -4.02M	$ -4.13M
Financing Cash Flow	$ 41.78M	$ -135.33M	$ 3.68M	$ -4.69M	$ 3.60M

Currency in USD

RVL Pharmaceuticals Earnings and Revenue History

Income Statement >

RVL Pharmaceuticals Debt to Assets

Balance Sheet >

RVL Pharmaceuticals Cash Flow

Cash Flow >

RVL Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing